Company / Inventory
NovoCure Ltd Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$41.1M
FY2025
5-year range
$24.4M / $41.1M
FY2021-FY2025
Trend
+17.2%
vs FY2024
Sector context
#96 of 118
Health Care
What the data says
NovoCure Ltd's inventory of $41M is lower than 81% of companies in the Health Care sector (FY2025). Inventory has fluctuated over the past 10 years, ranging from $22M in FY2017 to $41M in FY2025.
Based on SEC 10-K filings.
$41M in FY2025 with a 5-year CAGR of +8.4%.
Improved from $38M to $41M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +11.9%
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 118This company $41.1M Sector average $1.4B
▼
-97.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.4%, indicating consistent growth.
- In FY2025, inventory increased 17.2% year-over-year.
- Ranks #96 out of 118 companies in the Health Care sector.
- Lowest inventory in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $41.1M | +17.2% |
| FY2024 | $35.1M | -8.0% |
| FY2023 | $38.2M | +29.9% |
| FY2022 | $29.4M | +20.3% |
| FY2021 | $24.4M | -10.9% |
| FY2020 | $27.4M | +15.7% |
| FY2019 | $23.7M | +5.1% |
| FY2018 | $22.6M | +2.4% |
| FY2017 | $22.0M | -13.8% |
| FY2016 | $25.5M | +87.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026